Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PTPRG antagonists(protein tyrosine phosphatase receptor type G antagonists), PTPRZ1 antagonists(protein tyrosine phosphatase receptor type Z1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H18F3NO4S3 |
InChIKeyAKXBLDKCMACKRY-UHFFFAOYSA-N |
CAS Registry2809469-05-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | JP | 17 Jul 2017 |